Nicholas Smith joins Stanford phage pharmaceuticals research

Nicholas Smith will lead nuclear imaging and phage pharmacokinetics research and the pharmacology and modelling core at Stanford’s $9.5 million Center for Phage Pharmaceuticals. The NIAID-funded work focuses on optimizing respiratory phage delivery, beginning with Pseudomonas aeruginosa infections in cystic fibrosis.